Simple injection could ease chronic headaches for millions
NCT ID NCT07347730
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests whether injecting a steroid and numbing medicine into muscle trigger points can relieve chronic cervicogenic headaches (headaches that start from the neck). Over 1,000 adults aged 18-65 with at least 3 months of headaches will receive either the trigger point injection or a nerve block injection. Researchers will track pain, headache frequency, and quality of life for 2 years to see if the simpler injection works just as well.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
triamcinolone acetonide and lidocaine injection
What this could lead to
If successful, this could provide a simple, safe injection option for people with chronic cervicogenic headache who haven't found relief from other treatments.
What could go wrong
This is a non-inferiority trial, so it may only show that the injection is as good as, not better than, existing treatments. Long-term benefits and risks are still being studied.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICOGENIC HEADACHE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Tiantan Hospital
RECRUITINGBeijing, Beijing Municipality, 100070, China
Contact Phone: •••-•••-•••• Email: •••••@•••••